As follow up to the recent passage of the HIV Organ Policy Equity Act (HOPE), the Organ Procurement and Transplantation Network (OPTN) has named 15 clinicians and professionals involved in organ donation and transplantation to a work group to consider policy revisions to allow recovery of organs from HIV-positive deceased donors for use by HIV-infected patients in need of organ transplants. |
The HOPE Act, supported by the HIV Medicine Association (HIVMA), calls for the U.S. Department of Health and Human Services (DHHS) to develop and publish criteria for the conduct of research relating to the transplantation of organs from donors known to be HIV-positive to recipients who are HIV-positive. Together, DHHS and OPTN will review the results of the scientific research and assess the feasibility, effectiveness, and safety of using organs from HIV-positive donors. A key aspect in policy consideration is ensuring that HIV status would be properly identified at all stages of donation and transplantation.
Several HIVMA and IDSA members were among the 15 named to the OPTN work group including:
- Michael Green, MD, MPH, FIDSA, professor of pediatrics and surgery at the University of Pittsburgh School of Medicine
- Daniel Kaul, MD, FIDSA, director of the transplant infectious diseases service at the University of Michigan Medical Center
- Costi Sifri, MD, FIDSA, associate professor of medicine at the University of Virginia School of Medicine, and
- Cameron Wolfe, MD, attending faculty in transplant infectious disease at Duke University Medical Center.
< Previous Article | Next Article >